Free Trial

Trellus Health (TRLS) Competitors

GBX 0.50 -0.15 (-23.08%)
As of 07/11/2025 10:56 AM Eastern

TRLS vs. IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, COG, and INHC

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry.

Trellus Health vs. Its Competitors

IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings, media sentiment and risk.

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Trellus Health -12,114.55%-37.95%-22.76%

IQ-AI has a beta of 2.25, meaning that its share price is 125% more volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500.

In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Trellus Health Neutral

19.3% of Trellus Health shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by insiders. Comparatively, 49.7% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Trellus Health£65.83K14.68-£7.98M-£3.45-0.15

Summary

IQ-AI beats Trellus Health on 5 of the 9 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£967K£220.71M£5.62B£3.00B
Dividend YieldN/A6.68%5.24%5.02%
P/E Ratio-0.15379.2428.10150.83
Price / Sales14.68196.12429.70314,599.98
Price / Cash0.7647.1437.4627.97
Price / Book0.055.278.044.58
Net Income-£7.98M-£15.55M£3.18B£5.90B
7 Day Performance-23.08%-0.06%3.62%11.51%
1 Month Performance-40.48%-0.33%4.05%7.92%
1 Year Performance-67.02%14.19%30.00%32.01%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.50
-23.1%
N/A-68.2%£967K£65.83K-0.1531Gap Down
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-27.3%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
N/AGBX 2,200
+0.5%
GBX 2,800
+27.3%
-3.1%£945.27M£230.77M81.28734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
2.859 of 5 stars
GBX 192
-0.5%
GBX 456.67
+137.8%
-38.1%£70.47M£50.72M18.04478News Coverage
Analyst Forecast
RENX
Renalytix
N/AGBX 7
0.0%
N/A-59.5%£29.01M£9.22M-0.33102Gap Down
High Trading Volume
COG
Cambridge Cognition
N/AGBX 33
+3.1%
N/A-22.8%£13.82M£15.64M-8.7780
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A-2.5%£9.00M£12.57M-1.7674

Related Companies and Tools


This page (LON:TRLS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners